Clinical Trials Logo

Acquired Methaemoglobinaemia clinical trials

View clinical trials related to Acquired Methaemoglobinaemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT03395223 Completed - Clinical trials for Acquired Methaemoglobinaemia

MEthylene Blue In Patients With Acquired Methemoglobinemia

Start date: July 6, 2018
Phase: Phase 4
Study type: Interventional

This is an open label, uncontrolled, Phase 4 study including 10 patients who present in hospital/urgent care setting with acquired methemoglobinemia. The population may include pediatric and adult patients (males and females of all ages are included). The study will run in both the EU and the US. The aim of the study is to confirm safety and efficacy of ProvayBlueTM for the treatment of acquired methemoglobinemia and has been requested by the US-FDA as a Post-Marketing requirements.